NS

Nayan Samdariya

Director Director DIN 02023842
DIN 02023842 First appointment Apr 1996 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Apr 1996
Shareholding value β€’β€’β€’β€’ Premium profile

About Nayan Samdariya

Data last updated:

Nayan Samdariya was a Director at Pharmadeal Private Limited (1996–2019) and Director at Sosyo Infusions Private Limited (from 2013). The companies operate in Pharma.

DIN 02023842
Primary Designation Director
Industry Pharma
First Appointment 02 Apr 1996
Oldest Company Age 13 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pharmadeal Private Limited U02423MP1978PTC001431
Director02 Apr 19961978₹81.6 Lakh (FY 2021)Active
Sosyo Infusions Private Limited U24230MP2013PTC031322
Director22 Aug 20132013Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sosyo Infusions Private Limited
Pharmadeal Private Limited
Premium access

Shareholding and investment profile for Nayan Samdariya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nayan Samdariya

Nayan Samdariya was first appointed on 02 Apr 1996 as Director at Pharmadeal Private Limited. The most recent appointment on record is 22 Aug 2013 at Sosyo Infusions Private Limited.

Nayan Samdariya held 2 earlier board appointments: Pharmadeal Private Limited (Director, 02 Apr 1996 to 11 Apr 2019); Sosyo Infusions Private Limited (Director, from 22 Aug 2013).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available